• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘流行病学与风险因素

Asthma epidemiology and risk factors.

作者信息

Stern Jessica, Pier Jennifer, Litonjua Augusto A

机构信息

Division of Allergy, Immunology, and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Division of Allergy and Immunology, Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

Semin Immunopathol. 2020 Feb;42(1):5-15. doi: 10.1007/s00281-020-00785-1. Epub 2020 Feb 4.

DOI:10.1007/s00281-020-00785-1
PMID:32020334
Abstract

Asthma is a clinical syndrome that affects all age groups. Asthma prevalence worldwide has seen a rapid increase in the latter part of the last century. Recent data has shown that asthma prevalence has plateaued and even decreased in some areas of the world, despite continuing to increase in other areas of the world. Many risk factors have been associated with asthma and the differences in distributions of these risk factors may explain the differences in prevalence. This article will review recent trends in the prevalence of asthma and recent studies that investigate risk factors of asthma.

摘要

哮喘是一种影响所有年龄组的临床综合征。在上个世纪后半叶,全球哮喘患病率迅速上升。最近的数据显示,尽管世界其他地区的哮喘患病率仍在上升,但在世界某些地区,哮喘患病率已趋于平稳甚至有所下降。许多风险因素与哮喘相关,这些风险因素分布的差异可能解释了患病率的差异。本文将综述哮喘患病率的近期趋势以及调查哮喘风险因素的最新研究。

相似文献

1
Asthma epidemiology and risk factors.哮喘流行病学与风险因素
Semin Immunopathol. 2020 Feb;42(1):5-15. doi: 10.1007/s00281-020-00785-1. Epub 2020 Feb 4.
2
The rural-urban enigma of allergy: what can we learn from studies around the world?过敏的城乡之谜:我们能从世界各地的研究中学到什么?
Pediatr Allergy Immunol. 2015 Mar;26(2):95-102. doi: 10.1111/pai.12341. Epub 2015 Feb 18.
3
Worldwide trends in asthma morbidity and mortality. Explanation of trends.全球哮喘发病率和死亡率趋势。趋势解释。
Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep;66(2-3):85-9.
4
[Epidemiological survey of asthma in children aged 0-14 years in seven districts of Shanghai].[上海市七个区0-14岁儿童哮喘的流行病学调查]
Zhonghua Er Ke Za Zhi. 2014 Jan;52(1):17-22.
5
[Epidemiology of asthma and allergies. The prevalence of allergies increases worldwide, and asthma has reached his highest-ever prevalence in Europe: why?].[哮喘与过敏的流行病学。全球过敏症患病率上升,且哮喘在欧洲达到了有史以来的最高患病率:原因何在?]
Bull Acad Natl Med. 2005 Oct;189(7):1419-34; discussion 1434.
6
[Trends in the frequency of asthma and allergies].[哮喘和过敏症的发病频率趋势]
Epidemiol Prev. 2005 Mar-Apr;29(2 Suppl):86-90.
7
Time trends in asthma and wheeze in Swedish children 1996-2006: prevalence and risk factors by sex.1996-2006 年瑞典儿童哮喘和喘息的时间趋势:按性别划分的患病率和危险因素。
Allergy. 2010 Jan;65(1):48-55. doi: 10.1111/j.1398-9995.2009.02105.x. Epub 2009 Oct 1.
8
The problem of asthma in the Ukraine.乌克兰的哮喘问题。
Allergy Proc. 1995 Sep-Oct;16(5):269-73. doi: 10.2500/108854195778702666.
9
[The comparison of the indoor environmental factors associated with asthma and related allergies among school-child between urban and suburban areas in Beijing].[北京城区与郊区学龄儿童哮喘及相关过敏症的室内环境因素比较]
Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Jul;44(7):626-30.
10
Re.: "Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children".关于:“6个月时的抗生素暴露与6岁时的哮喘和过敏:1401名美国儿童队列研究结果”
Am J Epidemiol. 2011 Jun 1;173(11):1343; author reply 1344-5. doi: 10.1093/aje/kwr082. Epub 2011 Apr 8.

引用本文的文献

1
Analysis of gender- and age-stratified asthma burden: forecasting prevalence trends in 2030.按性别和年龄分层的哮喘负担分析:预测2030年的患病率趋势
Front Med (Lausanne). 2025 Aug 20;12:1612688. doi: 10.3389/fmed.2025.1612688. eCollection 2025.
2
Inhaled Cannabis, Asthma, and Chronic Obstructive Pulmonary Disease: A Population-Based Cross-Sectional Study of n = 379,049.吸入大麻、哮喘与慢性阻塞性肺疾病:一项基于人群的横断面研究,样本量n = 379,049
J Gen Intern Med. 2025 Sep 4. doi: 10.1007/s11606-025-09833-8.
3
Implicates of PIP5K1α in asthma-related biological processes: insights into mechanisms and therapeutic potential.

本文引用的文献

1
Observational studies of vitamin D associations with asthma: Problems and pitfalls.维生素D与哮喘关联的观察性研究:问题与陷阱
Pediatr Pulmonol. 2018 Oct;53(10):1338-1339. doi: 10.1002/ppul.24131. Epub 2018 Jul 12.
2
Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma.二手烟暴露与哮喘对非裔美国人和拉丁裔哮喘儿童的影响。
Thorax. 2018 Nov;73(11):1041-1048. doi: 10.1136/thoraxjnl-2017-211383. Epub 2018 Jun 13.
3
Antibiotics as Instigators of Microbial Dysbiosis: Implications for Asthma and Allergy.
磷脂酰肌醇-4-磷酸5-激酶1α(PIP5K1α)在哮喘相关生物学过程中的作用:对机制及治疗潜力的见解
J Transl Med. 2025 Sep 2;23(1):978. doi: 10.1186/s12967-025-06997-z.
4
Mulberroside A ameliorates murine allergic airway inflammation by suppressing Th2 response and oxidative stress.桑色素A通过抑制Th2反应和氧化应激来改善小鼠过敏性气道炎症。
Inflammopharmacology. 2025 Aug 18. doi: 10.1007/s10787-025-01895-8.
5
Study on identification and analysis of biomarkers related to neutrophils extracellular traps in childhood asthma.儿童哮喘中性粒细胞胞外诱捕网相关生物标志物的鉴定与分析研究
Medicine (Baltimore). 2025 Aug 1;104(31):e43489. doi: 10.1097/MD.0000000000043489.
6
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.用于治疗炎症性肺部疾病的基于纳米技术的可吸入药物递送系统。
Pharmaceutics. 2025 Jul 9;17(7):893. doi: 10.3390/pharmaceutics17070893.
7
Plant-based diets, genetic predisposition, and the risk of adult-onset asthma A prospective study.植物性饮食、遗传易感性与成人期哮喘风险:一项前瞻性研究
Eur J Nutr. 2025 Jul 28;64(6):249. doi: 10.1007/s00394-025-03757-z.
8
Bioaerosols and Airway Diseases: Mechanisms of Epithelial Dysfunction, Immune Activation, and Strategies for Exposure Mitigation.生物气溶胶与气道疾病:上皮功能障碍、免疫激活机制及暴露缓解策略
Arch Intern Med Res. 2025;8(3):178-191. doi: 10.26502/aimr.0210. Epub 2025 Jul 3.
9
Profile of mild/moderate asthma patients: Baseline data from the MANI cohort.轻度/中度哮喘患者概况:来自MANI队列的基线数据。
World Allergy Organ J. 2025 Jul 3;18(8):101082. doi: 10.1016/j.waojou.2025.101082. eCollection 2025 Aug.
10
Related Risk Factors That Predict Moderate to Severe Asthma Attack in Children: Analysis Based on Logistic Regression and Decision Tree.预测儿童中重度哮喘发作的相关危险因素:基于逻辑回归和决策树的分析
Int J Gen Med. 2025 Jul 15;18:3919-3931. doi: 10.2147/IJGM.S530736. eCollection 2025.
抗生素引发微生物失调:对哮喘和过敏的影响。
Trends Immunol. 2018 Sep;39(9):697-711. doi: 10.1016/j.it.2018.02.008. Epub 2018 Apr 11.
4
Assessing the impact of air pollution on childhood asthma morbidity: how, when, and what to do.评估空气污染对儿童哮喘发病率的影响:如何评估、何时评估以及该怎么做。
Curr Opin Allergy Clin Immunol. 2018 Apr;18(2):124-131. doi: 10.1097/ACI.0000000000000422.
5
Dog introduction alters the home dust microbiota.狗的引入改变了家庭灰尘中的微生物群落。
Indoor Air. 2018 Jul;28(4):539-547. doi: 10.1111/ina.12456. Epub 2018 Mar 13.
6
Evidence establishing a link between prenatal and early-life stress and asthma development.证实产前及生命早期压力与哮喘发展之间存在关联的证据。
Curr Opin Allergy Clin Immunol. 2018 Apr;18(2):148-158. doi: 10.1097/ACI.0000000000000421.
7
Outdoor pollen is a trigger of child and adolescent asthma emergency department presentations: A systematic review and meta-analysis.户外花粉是儿童和青少年哮喘急诊发作的诱因:系统评价和荟萃分析。
Allergy. 2018 Aug;73(8):1632-1641. doi: 10.1111/all.13407. Epub 2018 Mar 2.
8
Prenatal maternal psychosocial stress and offspring's asthma and allergic disease: A systematic review and meta-analysis.产前母体心理社会压力与后代哮喘和过敏性疾病:系统评价和荟萃分析。
Clin Exp Allergy. 2018 Apr;48(4):403-414. doi: 10.1111/cea.13091. Epub 2018 Feb 8.
9
Indoor Environmental Interventions for Furry Pet Allergens, Pest Allergens, and Mold: Looking to the Future.室内环境干预措施以减少宠物过敏原、害虫过敏原和霉菌:展望未来。
J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):9-19. doi: 10.1016/j.jaip.2017.10.009.
10
Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials.产前补充维生素D可降低幼儿患哮喘/复发性喘息的风险:两项随机对照试验的综合分析。
PLoS One. 2017 Oct 27;12(10):e0186657. doi: 10.1371/journal.pone.0186657. eCollection 2017.